Judith Adams

Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection1

É. Kiss, H. Gröne, J. Wagner, 2003, Transplantation.

Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.

E. Ritz, K. Amann, H. Ogata, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy.

N. Gretz, Qiang Sun, É. Kiss, 2005, The American journal of pathology.

Renal transplantation in children with malformations of the urinary tract.

O. Mehls, C. Güdemann, M. Wiesel, 2002, Transplantation proceedings.

Intestinal reconstruction of the lower urinary tract as a prerequisite for renal transplantation

B. Toenshoff, M. Hohenfellner, Jan Schmidt, 2009, BJU international.

Ureteric replacement with Meckel’s diverticulum

M. Hohenfellner, J. Pfitzenmaier, A. Haferkamp, 2007, BJU international.

Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.

N. Gretz, D. Teupser, É. Kiss, 2011, The American journal of pathology.

Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage.

N. Gretz, A. Abdollahi, S. Domhan, 2010, The American journal of pathology.